📢 Early Registration Deadline Alert! Hurry to register for #EAPS2024 by 11 July to enjoy special rates and join us in Vienna and Online for the premier paediatric event of the year: invt.io/1txbrd6mqsj
2
11
Łukasz Dembiński retweeted
Check out the latest #ECDC podcast on epidemiology in the field ow.ly/2Hgt50PL1BB
Łukasz Dembiński retweeted
Tomorrow Barbara Rath will be talking about @ImmuHubs
🔵Within the framework of the #VaccinAction2023 EU project, @activecitnet is glad to invite you to the online event titled “Healthy Living, healthy ageing: the burden of VPDs in the European Adult population - what if we do nothing?”
👉us06web.zoom.us/webinar/regi…
Łukasz Dembiński retweeted
Look out for the session on 18/9/23 at the ESWI conference (Science Policy Interface, SPI) #Valencia on how to improve vaccine uptake among risk groups and HCW #vaccineswork #vaccinessavelives
Łukasz Dembiński retweeted
ImmuHubs Poland: In collaboration with Provincial Sanitary and Epidemiological Station in Stalowa Wola, in Rzeszów and in Przemyśl meetings for Seasonal Ukrainian Workers and Ukrainian war refugees were organized. Good job!
Łukasz Dembiński retweeted
#Influenza and #pneumonia #vaccinations associated with reduced risk of Alzheimer’s disease
aaic.alz.org/releases_2020/v…
Łukasz Dembiński retweeted
@ImmuHubs - Serbia: new brochure for parents, teachers, and policymakers "Information Sheet on Coronavirus Vaccination and Guidelines for Working with Adolescents" by Milica Lazi
@Univerzitet_BG
digitalna.ff.uns.ac.rs/bibli…
Łukasz Dembiński retweeted
A new study by @UniofOxford scientists finds #Malaria vaccine candidate to appear safe and produce a promising immune response in a cohort of Tanzanian infants. @CellPressNews #paediatricHealth #OneHealth #vaccineswork
DOI:doi.org/10.1016/j.medj.2023.…
Łukasz Dembiński retweeted
New publication by @ImmuHubs Serbia: "Sociopsychological aspects of vaccination against COVID -19 among young people in Vojvodina"
@Univerzitet_BG
digitalna.ff.uns.ac.rs/bibli…
Łukasz Dembiński retweeted
The primary objective of the European Network of Paediatric Research at the @EMA_News (Enpr-EMA) is to facilitate clinical trials to increase the availability of authorised medicines for children. The next workshop is on 10/10/2023!💪 #fridays4future
ow.ly/PRXQ50Py0sO
Łukasz Dembiński retweeted
New investigational 21-valent #pneumococcal conjugate #vaccine immunogenic and safe!
@Merck
merck.com/news/merck-announc…
Łukasz Dembiński retweeted
Find out what are the #COVID19 #vaccination rates in immigrant and refugee children and adolescents
jamanetwork.com/journals/jam…
Łukasz Dembiński retweeted
#immunisation coverage is recovering and improving but there is still work to do - read more from the @WHO here who.int/news-room/fact-sheet… #vaccinessavelives #vaccineswork
Łukasz Dembiński retweeted
#TB is a huge global problem. New treatments are badly needed, read more about one here sciencedaily.com/releases/20…
Łukasz Dembiński retweeted
Cases of #malaria have been identified in the US - experts answer questions here infectioncontroltoday.com/vi…
Łukasz Dembiński retweeted
Keep up to date with the latest @WHO disease outbreak news here who.int/emergencies/disease-…
Łukasz Dembiński retweeted
🤗Today is World Hepatitis Day!
It is on the birthday of Nobel-prize-winning scientist Dr. Baruch Blumberg, who discovered the hepatitis B virus (HBV) and developed a diagnostic test and vaccine. #vaccinessavelives #WorldHepatitisDay #HepAware
worldhepatitisday.org/






